CoChat

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Dopamine Oxidation and Autophagy

Open access
Muñoz, Patricia, Huenchuguala, Sandro, Paris, Irmgard, Segura-Aguilar, Juan · 2012 · Parkinson's Disease

Abstract

The molecular mechanisms involved in the neurodegenerative process of Parkinson's disease remain unclear. Currently, there is a general agreement that mitochondrial dysfunction, α -synuclein aggregation, oxidative stress, neuroinflammation, and impaired protein degradation are involved in the neurodegeneration of dopaminergic neurons containing neuromelanin in Parkinson's disease. Aminochrome has been proposed to play an essential role in the degeneration of dopaminergic neurons containing neuromelanin by inducing mitochondrial dysfunction, oxidative stress, the formation of neurotoxic α -synuclein protofibrils, and impaired protein degradation. Here, we discuss the relationship between the oxidation of dopamine to aminochrome, the precursor of neuromelanin, autophagy dysfunction in dopaminergic neurons containing neuromelanin, and the role of dopamine oxidation to aminochrome in autophagy dysfunction in dopaminergic neurons. Aminochrome induces the following: (i) the formation of α -synuclein protofibrils that inactivate chaperone-mediated autophagy; (ii) the formation of adducts with α - and β -tubulin, which induce the aggregation of the microtubules required for the fusion of autophagy vacuoles and lysosomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2012/920953

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Dopamine synthesis. Synthesis of dopamine catalyzed by tyrosine hydroxylase (TH) and aromatic amino acid decarboxylase (AADC), which are both associated with the vesicular monoaminergic transporter-2 (VMAT-2).
Figure 1 Dopamine synthesis. Synthesis of dopamine catalyzed by tyrosine hydroxylase (TH) and aromatic amino acid decarboxylase (AADC), which are both associated with the vesicular monoaminergic transporter-2 (VMAT-2).CC BY · PubMed Central
Figure 2 Dopamine degradation catalyzed by MAO and COMT. Dopamine oxidation to aminochrome is prevented by dopamine degradation mediated by both MAO and COMT. MAO catalyzes the oxidative deamination of dopamine amino group to 3,4-dihydroxyphenylacetaldehyde, that is converted to 3,4-dihydroxyphenylacetic acid (DOPAC) catalyzed by aldehyde dehydrogenase. COMT catalyzes the methylation of dopamine to 3-methoxytyramine that is substrate for MAO that catalyzes the formation of 3-metoxy-4-hydroxyphenylacetaldehyde. Homovanillic acid is formed when MAO uses 3-metoxy-4-hydroxyphenylacetaldehyde as substrate or when DOPAC is metabolized by COMT.
Figure 2 Dopamine degradation catalyzed by MAO and COMT. Dopamine oxidation to aminochrome is prevented by dopamine degradation mediated by both MAO and COMT. MAO catalyzes the oxidative deamination of dopamine amino group to 3,4-dihydroxyphenylacetaldehyde, that is converted to 3,4-dihydroxyphenylacetic acid (DOPAC) catalyzed by aldehyde dehydrogenase. COMT catalyzes the methylation of dopamine to 3-methoxytyramine that is substrate for MAO that catalyzes the formation of 3-metoxy-4-hydroxyphenylacetaldehyde. Homovanillic acid is formed when MAO uses 3-metoxy-4-hydroxyphenylacetaldehyde as substrate or when DOPAC is metabolized by COMT.CC BY · PubMed Central
Figure 3 Dopamine oxidation to aminochrome at physiological pH. Dissociated dopamine can be oxidized to a dopamine o-semiquinone radical by the reduction of one molecule of oxygen to form a superoxide radical. The dopamine o-semiquinone radical can then disproportionate with another dopamine o-semiquinone radical, generating one molecule of dopamine and one molecule of dopamine o-quinone. Alternatively, the dopamine o-semiquinone radical can undergo one-electron oxidation to dopamine o-quinone by reducing one molecule of molecular oxygen to a superoxide radical. Dopamine o-quinone immediately cyclizes to form aminochrome, which is only stable in environments below pH 2.
Figure 3 Dopamine oxidation to aminochrome at physiological pH. Dissociated dopamine can be oxidized to a dopamine o-semiquinone radical by the reduction of one molecule of oxygen to form a superoxide radical. The dopamine o-semiquinone radical can then disproportionate with another dopamine o-semiquinone radical, generating one molecule of dopamine and one molecule of dopamine o-quinone. Alternatively, the dopamine o-semiquinone radical can undergo one-electron oxidation to dopamine o-quinone by reducing one molecule of molecular oxygen to a superoxide radical. Dopamine o-quinone immediately cyclizes to form aminochrome, which is only stable in environments below pH 2.CC BY · PubMed Central
Figure 4 Neuromelanin formation. Dopamine is oxidized to aminochrome, which tautomerizes to 5,6-indolequinone and undergoes polymerization to form the dark pigment neuromelanin.
Figure 4 Neuromelanin formation. Dopamine is oxidized to aminochrome, which tautomerizes to 5,6-indolequinone and undergoes polymerization to form the dark pigment neuromelanin.CC BY · PubMed Central
Figure 5 Aminochrome forms adducts with proteins. Aminochrome forms adducts with proteins, such as DJ-1, isocitrate dehydrogenase, and complex I and III of mitochondria, inducing mitochondrial dysfunction and an energy collapse. Adducts formed with α-synuclein, induces the formation of neurotoxic α-synuclein protofibrils, which inactivate chaperone-mediated autophagy and impair the proteasomal system, resulting in the dysfunction of protein degradation. Aminochrome adducts formed with α- and β-tubulin induces the aggregation of microtubules that are required for the fusion of autophagy vacuoles with lysosomes. Aminochrome also forms adducts with UCHL-1.
Figure 5 Aminochrome forms adducts with proteins. Aminochrome forms adducts with proteins, such as DJ-1, isocitrate dehydrogenase, and complex I and III of mitochondria, inducing mitochondrial dysfunction and an energy collapse. Adducts formed with α-synuclein, induces the formation of neurotoxic α-synuclein protofibrils, which inactivate chaperone-mediated autophagy and impair the proteasomal system, resulting in the dysfunction of protein degradation. Aminochrome adducts formed with α- and β-tubulin induces the aggregation of microtubules that are required for the fusion of autophagy vacuoles with lysosomes. Aminochrome also forms adducts with UCHL-1.CC BY · PubMed Central
Figure 6 One-electron reduction of aminochrome. The one-electron reduction of aminochrome is catalyzed by flavoenzymes that utilize NADH as an electron donor, generating leukoaminochrome o-semiquinone radical. This radical is extremely reactive with oxygen and autoxidizes by reducing molecular oxygen to superoxide radicals. This redox cycling induces oxidative stress and depletes the NADH required for the generation of energy (ATP) in the mitochondria. Redox cycling can also be catalyzed by flavoenzymes that utilize NADPH as an electron donor, depleting the NADPH required for the reduction of oxidized glutathione.
Figure 6 One-electron reduction of aminochrome. The one-electron reduction of aminochrome is catalyzed by flavoenzymes that utilize NADH as an electron donor, generating leukoaminochrome o-semiquinone radical. This radical is extremely reactive with oxygen and autoxidizes by reducing molecular oxygen to superoxide radicals. This redox cycling induces oxidative stress and depletes the NADH required for the generation of energy (ATP) in the mitochondria. Redox cycling can also be catalyzed by flavoenzymes that utilize NADPH as an electron donor, depleting the NADPH required for the reduction of oxidized glutathione.CC BY · PubMed Central
Figure 7 Two-electron reduction of aminochrome catalyzed by DT-diaphorase. DT-diaphorase prevents the participation of aminochrome in neurotoxic reactions, such as the formation of adducts with proteins and one-electron reduction of aminochrome to leukoaminochrome.
Figure 7 Two-electron reduction of aminochrome catalyzed by DT-diaphorase. DT-diaphorase prevents the participation of aminochrome in neurotoxic reactions, such as the formation of adducts with proteins and one-electron reduction of aminochrome to leukoaminochrome.CC BY · PubMed Central
Figure 8 Glutathione conjugation of dopamine o-quinone and aminochrome. GST M2-2 catalyzes conjugation of both aminochrome and its precursor dopamine o-quinone to 4-S-glutathionyl-5,6-dihydroxyindoline and 5-glutathionyl-dopamine, respectively. 5-Glutathionyl-dopamine undergoes degradation to 5-cysteinyl dopamine that have been found in both the cerebrospinal fluid and neuromelanin.
Figure 8 Glutathione conjugation of dopamine o-quinone and aminochrome. GST M2-2 catalyzes conjugation of both aminochrome and its precursor dopamine o-quinone to 4-S-glutathionyl-5,6-dihydroxyindoline and 5-glutathionyl-dopamine, respectively. 5-Glutathionyl-dopamine undergoes degradation to 5-cysteinyl dopamine that have been found in both the cerebrospinal fluid and neuromelanin.CC BY · PubMed Central
Figure 9 The effects of aminochrome on β-tubulin (a–d) and the accumulation of autophagosomes in the cytosol of cells treated with aminochrome (e). RCSN-3 cells were treated with cell culture medium (a), 100 μM dicoumarol (b), 50 μM aminochrome (c), and 50 μM aminochrome and 100 μM dicoumarol (d) and incubated for 48 h as described by Paris et al. 2010 [15]. In (e) the number of autophagosomes per cell was determined by incubating RCSN3 cells for 24 h with cell culture medium (Co), 100 μM dicoumarol (Di), 10 μM vinblastine (V), 20 μM aminochrome (AM), 20 μM aminochrome and 100 μM dicoumarol (AMDi), 20 μM aminochrome and 100 μM dicoumarol and 10 μM vinblastine (AMDiV). As a positive control, cells were incubated with cell culture medium without bovine serum (Co+). The statistical significance was assessed using ANOVA for multiple comparisons and Student's t test (***P < 0.001). This experiment was performed as described by Paris et al. 2011 [40].
Figure 9 The effects of aminochrome on β-tubulin (a–d) and the accumulation of autophagosomes in the cytosol of cells treated with aminochrome (e). RCSN-3 cells were treated with cell culture medium (a), 100 μM dicoumarol (b), 50 μM aminochrome (c), and 50 μM aminochrome and 100 μM dicoumarol (d) and incubated for 48 h as described by Paris et al. 2010 [15]. In (e) the number of autophagosomes per cell was determined by incubating RCSN3 cells for 24 h with cell culture medium (Co), 100 μM dicoumarol (Di), 10 μM vinblastine (V), 20 μM aminochrome (AM), 20 μM aminochrome and 100 μM dicoumarol (AMDi), 20 μM aminochrome and 100 μM dicoumarol and 10 μM vinblastine (AMDiV). As a positive control, cells were incubated with cell culture medium without bovine serum (Co+). The statistical significance was assessed using ANOVA for multiple comparisons and Student's t test (***P < 0.001). This experiment was performed as described by Paris et al. 2011 [40].CC BY · PubMed Central
Figure 10 Possible role of aminochrome in autophagy. Aminochrome induces the dysfunction of autophagy by forming adducts with the following: (i) alpha synuclein, which inactivates chaperone-mediated autophagy; and (ii) α- and β-tubulin, inducing the aggregation of microtubules, which are essential for the fusion of autophagy vacuoles with lysosomes.
Figure 10 Possible role of aminochrome in autophagy. Aminochrome induces the dysfunction of autophagy by forming adducts with the following: (i) alpha synuclein, which inactivates chaperone-mediated autophagy; and (ii) α- and β-tubulin, inducing the aggregation of microtubules, which are essential for the fusion of autophagy vacuoles with lysosomes.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Research works printed but not linked: 5

  1. 1995, Biometals, 25, 795
  2. 2006, Society for Neuroscience, 824, article 17
  3. 2008, Neurotoxicity Research, 13, article 136
  4. 1984, Journal of Chromatography, 311, 154
  5. 2012, Cold Spring Harbor Perspectives in Medicine, 2, 1

Cited by

See all 214

Metadata

Authors
Muñoz, P., Huenchuguala, S., Paris, I., & Segura-Aguilar, J.
Affiliations
  • University of Chile (CL)
  • Universidad Santo Tomás (CL)
  • Molecular & Clinical Pharmacology, ICBM, Faculty of Medicine, University of Chile, Independencia 1027, Santiago 8380453, Chile
Venue
Parkinson's Disease
Publisher
Wiley
Published
2012
Volume
2012
Pages
1-13
ISSN
  • 2042-0080 (ISSN-L)
  • 2090-8083
OpenAlex
W2096782959
Cited by
214
References
75
Citations by year
2026: 13 · 2025: 18 · 2024: 9 · 2023: 20 · 2022: 25 · 2021: 22 · 2020: 15 · 2019: 23 · 2018: 12 · 2017: 16 · 2016: 12 · 2015: 11 · 2014: 14 · 2013: 4
FWCI
6.06
Type
journal article
Language
en
Open access
Locations
  • Parkinson s Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Funders
Fondo Nacional de Desarrollo Científico y Tecnológico (1100165)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
dopamine oxidation, aminochrome, neuromelanin, autophagy dysfunction, dopaminergic neurons, chaperone-mediated autophagy, mitochondrial dysfunction, oxidative stress, neuroinflammation, protein degradation, lysosome fusion

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopamine Oxidation and Autophagy. https://app.cochat.ai/papers/10.1155/2012/920953
The paper
Muñoz, P., Huenchuguala, S., Paris, I., & Segura-Aguilar, J. (2012). Dopamine Oxidation and Autophagy. Parkinson's Disease. https://doi.org/10.1155/2012/920953

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.